Cargando…

Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor

Tumors are a serious threat to human health. The oncolytic virus is a kind of tumor killer virus which can infect and lyse cancer cells and spread through the tumor, while leaving normal cells largely unharmed. Mathematical models can help us to understand the tumor-virus dynamics and find better tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Yongmei, Jia, Chen, Chen, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210284/
https://www.ncbi.nlm.nih.gov/pubmed/28097139
http://dx.doi.org/10.1155/2016/5621313
_version_ 1782490853141381120
author Su, Yongmei
Jia, Chen
Chen, Ying
author_facet Su, Yongmei
Jia, Chen
Chen, Ying
author_sort Su, Yongmei
collection PubMed
description Tumors are a serious threat to human health. The oncolytic virus is a kind of tumor killer virus which can infect and lyse cancer cells and spread through the tumor, while leaving normal cells largely unharmed. Mathematical models can help us to understand the tumor-virus dynamics and find better treatment strategies. This paper gives a new mathematical model of tumor therapy with oncolytic virus and MEK inhibitor. Stable analysis was given. Because mitogen-activated protein kinase (MEK) can not only lead to greater oncolytic virus infection into cancer cells, but also limit the replication of the virus, in order to provide the best dosage of MEK inhibitors and balance the positive and negative effect of the inhibitors, we put forward an optimal control problem of the inhibitor. The optimal strategies are given by theory and simulation.
format Online
Article
Text
id pubmed-5210284
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-52102842017-01-17 Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor Su, Yongmei Jia, Chen Chen, Ying Biomed Res Int Research Article Tumors are a serious threat to human health. The oncolytic virus is a kind of tumor killer virus which can infect and lyse cancer cells and spread through the tumor, while leaving normal cells largely unharmed. Mathematical models can help us to understand the tumor-virus dynamics and find better treatment strategies. This paper gives a new mathematical model of tumor therapy with oncolytic virus and MEK inhibitor. Stable analysis was given. Because mitogen-activated protein kinase (MEK) can not only lead to greater oncolytic virus infection into cancer cells, but also limit the replication of the virus, in order to provide the best dosage of MEK inhibitors and balance the positive and negative effect of the inhibitors, we put forward an optimal control problem of the inhibitor. The optimal strategies are given by theory and simulation. Hindawi Publishing Corporation 2016 2016-12-21 /pmc/articles/PMC5210284/ /pubmed/28097139 http://dx.doi.org/10.1155/2016/5621313 Text en
spellingShingle Research Article
Su, Yongmei
Jia, Chen
Chen, Ying
Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor
title Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor
title_full Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor
title_fullStr Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor
title_full_unstemmed Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor
title_short Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor
title_sort optimal control model of tumor treatment with oncolytic virus and mek inhibitor
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210284/
https://www.ncbi.nlm.nih.gov/pubmed/28097139
http://dx.doi.org/10.1155/2016/5621313
work_keys_str_mv AT suyongmei optimalcontrolmodeloftumortreatmentwithoncolyticvirusandmekinhibitor
AT jiachen optimalcontrolmodeloftumortreatmentwithoncolyticvirusandmekinhibitor
AT chenying optimalcontrolmodeloftumortreatmentwithoncolyticvirusandmekinhibitor